Accenture Lifts Outlook, Shares Lag

Accenture is riding a wave of strong quarterly numbers—$16.1 billion in Q3 revenue, up 10% year-over-year, with raised guidance for 2026. But investors aren’t convinced: the stock is stuck near a 52-week low, down about 45% in twelve months, even as insider buying ticks up. The disconnect? AI bookings are climbing, but the market wants to see those turn into fatter profit margins, not just higher sales. With a $65 billion backlog and deepening partnerships with ServiceNow and Microsoft, the question is whether all this AI momentum will translate into real earnings growth.

But here’s the catch: inside Accenture, AI is driving serious productivity—nearly 90% of heavy Copilot users say they’d miss it, and tasks are reportedly being completed up to 15 times faster. Yet outside, many executives still aren’t seeing measurable AI impact on their bottom lines. The stakes are high as Accenture tries to bridge internal wins with client ROI, especially with new investments in AI upstarts like Netomi and XBOW. Meanwhile, Anthropic is muscling into the mid-market with a new services arm backed by heavyweights like Goldman Sachs, promising faster and possibly cheaper AI rollouts that could squeeze Accenture’s margins in certain sectors.

On the sports front, Accenture landed a headline-grabbing partnership with the WTA to overhaul women’s tennis operations using AI. If they can turn the WTA Player Zone into a replicable digital platform, it could become both a showcase and a springboard for similar deals across global sports—and a way to prove, in black and white, that AI delivers results worth paying for. Featuring insights from Accenture’s Mauro Macchi and WTA Ventures’ Marina Storti, plus reporting from Modern Healthcare and Sportcal.

Powered by Apisod.com